Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Bravo, A; de Lucio, H; Sánchez-Murcia, PA; Jiménez-Ruiz, A; Petrone, PM; Gago, F; Cortés Cabrera, A.
Identification of NEK3 and MOK as novel targets for lithium.
Chem Biol Drug Des. 2019; 93(5):965-969 Doi: 10.1111/cbdd.13487
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz
Sánchez Murcia Pedro Alejandro
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Lithium ion, commonly used as the carbonate salt in the treatment of bipolar disorders, has been identified as an inhibitor of several kinases, including Glycogen Synthase Kinase-3β, for almost 20 years. However, both the exact mechanism of enzymatic inhibition and its apparent specificity for certain metalloenzymes are still a matter of debate. A data-driven hypothesis is presented that accounts for the specificity profile of kinase inhibition by lithium in terms of the presence of a unique protein environment in the magnesium-binding site. This hypothesis has been validated by the discovery of two novel potential targets for lithium, namely NEK3 and MOK, which are related to neuronal function. © 2019 John Wiley & Sons A/S.
Find related publications in this database (using NLM MeSH Indexing)
Antigens, Neoplasm - chemistry
Antigens, Neoplasm - metabolism
Binding Sites -
Glycogen Synthase Kinase 3 beta - chemistry
Glycogen Synthase Kinase 3 beta - metabolism
Humans -
Inhibitory Concentration 50 -
Ions - chemistry
Lithium - chemistry
Lithium - metabolism
Magnesium - chemistry
Magnesium - metabolism
Mitogen-Activated Protein Kinases - chemistry
Mitogen-Activated Protein Kinases - metabolism
Molecular Dynamics Simulation -
NIMA-Related Kinases - chemistry
NIMA-Related Kinases - metabolism
Protein Structure, Tertiary -

Find related publications in this database (Keywords)
axonal growth
bipolar disorder
GSK3B
lithium
MOK
NEK3
© Med Uni GrazImprint